KRAS and neoplasm: These results indicate that the observed overexpression of the TNFA signaling via NFKB and P53 Pathway in bulk RNA sequencing data from tumor samples is likely not related to tumor purity, whereas the observed KRAS signaling and IL2/STAT5 signaling overexpression may be in part attributable to lower tumor purity.